Literature DB >> 11560065

Beginning to manage drug discovery and development knowledge.

M Sumner-Smith1.   

Abstract

Knowledge management approaches and technologies are beginning to be implemented by the pharmaceutical industry in support of new drug discovery and development processes aimed at greater efficiencies and effectiveness. This trend coincides with moves to reduce paper, coordinate larger teams with more diverse skills that are distributed around the globe, and to comply with regulatory requirements for electronic submissions and the associated maintenance of electronic records. Concurrently, the available technologies have implemented web-based architectures with a greater range of collaborative tools and personalization through portal approaches. However, successful application of knowledge management methods depends on effective cultural change management, as well as proper architectural design to match the organizational and work processes within a company.

Mesh:

Year:  2001        PMID: 11560065

Source DB:  PubMed          Journal:  Curr Opin Drug Discov Devel        ISSN: 1367-6733


  1 in total

1.  A call to restructure the drug development process: government over-regulation and non-innovative late stage (Phase III) clinical trials are major obstacles to advances in health care.

Authors:  Thomas C Jones
Journal:  Sci Eng Ethics       Date:  2005-10       Impact factor: 3.525

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.